Michael A. Curran
University of Texas MD Anderson Cancer Center
45 papers found
Refreshing results…
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Download from doi.orgOncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Download from www.nature.comEnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy
Download from doi.orgMissing publications? Search for publications with a matching author name.